Annals of Oncology · 2019 · 944 citations · 23 references
MedicineOncologyPharmacotherapyImmunotherapyOncology PharmacotherapyTumor ProgressionCancer ImmunotherapyCancer Survival AnalysisImmune Checkpoint InhibitorsImmunotherapy For Skin CancerMelanoma PharmacotherapyTargeted Cancer TherapyAdvanced Cutaneous Squamous Cell Carcinoma TherapyMelanoma ImmunotherapyMelanoma ProgressionMetastatic Melanoma TreatmentPembrolizumab Therapy
23
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.9K citations · Full text
Medicine, Immunology, Oncology +17